FDA — authorised 17 May 2018
- Marketing authorisation holder: AMGEN INC
- Status: approved
🇺🇸 Aimovig in United States
FDA authorised Aimovig on 17 May 2018
Marketing authorisations
FDA — authorised 22 September 2022
- Application: BLA761077
- Marketing authorisation holder: AMGEN INC
- Indication: Labeling
- Status: approved
Aimovig in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Aimovig approved in United States?
Yes. FDA authorised it on 17 May 2018; FDA authorised it on 22 September 2022.
Who is the marketing authorisation holder for Aimovig in United States?
AMGEN INC holds the US marketing authorisation.